India  

Covid vaccine should be available for public by April 2021: Serum Institute CEO

IndiaTimes Friday, 20 November 2020
Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford Covid-19 vaccine should be available for healthcare workers and elderly people by around February 2021 and by April for the general public, and will be priced at a maximum of Rs 1,000 for two necessary doses for the public, depending on the final trial results and regulatory approvals.
0
shares
ShareTweetSavePostSend
 
Video Credit: HT Digital Content - Published
News video: Covid, vaccine race & what we don't know yet | Dr Guleria & Dr Jha #HTLS2020

Covid, vaccine race & what we don't know yet | Dr Guleria & Dr Jha #HTLS2020 32:54

The opening session of the 18th edition of the Hindustan Times Leadership Summit saw an enlightening discussion on the Covid-19 pandemic. Dr Ashish K. Jha, Dean, Brown University School of Public Health, and Dr Randeep Guleria, Director, All India Institute of Medical Sciences spoke on the race for a...

💡 newsR Knowledge: Other News Mentions

COVID-19 COVID-19 Disease caused by severe acute respiratory syndrome coronavirus 2

Hear doctor's emotional plea for people to get vaccinated [Video]

Hear doctor's emotional plea for people to get vaccinated

Dr. Michael Bolding made an emotional plea for people in Arkansas to get the Covid-19 vaccine. He speaks with CNN’s Pamela Brown about what it has been like treating unvaccinated patients as cases surge.

Credit: Bleacher Report AOL    Duration: 03:37Published
On GPS: Covid's Delta variant wreaks havoc [Video]

On GPS: Covid's Delta variant wreaks havoc

Tom Frieden and Devi Sridhar join Fareed to break down what can be done in the face of the highly contagious Delta variant.

Credit: Bleacher Report AOL    Duration: 04:26Published
On GPS: What to make of Covid "Breakthrough infections" [Video]

On GPS: What to make of Covid "Breakthrough infections"

Tom Frieden, Devi Sridhar and Fareed on the likelihood of becoming infected with Covid-19 in spite of being fully vaccinated.

Credit: Bleacher Report AOL    Duration: 06:26Published
Stelter: News coverage should help you assess Covid-19 risk [Video]

Stelter: News coverage should help you assess Covid-19 risk

Brian Stelter says news coverage sometimes misses the nuances of Covid-19 risks, like the fact that the current surge in cases is “very unevenly distributed.” He says “we all have to think more like risk calculators” when covering and dealing with Covid.”

Credit: Bleacher Report AOL    Duration: 02:11Published

Serum Institute of India Serum Institute of India Indian biotechnology and biopharmaceuticals company

No application received from SII for EU authorisation of Covishield vaccine: EMA

Poonawalla last month said that he was 'taking this up at the highest levels with regulators and diplomats' and that he hoped to resolve this matter.
DNA

No application received for EU authorisation of Covishield, says European Medicines Agency

The European Medicines Agency (EMA) said it has not received any application from the Covid-19 vaccine Covishield maker Serum Institute of India (SII) for..
IndiaTimes
Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News [Video]

Health Ministry: '3rd wave predictions treated casually like weather forecast' | Oneindia News

Today, the health ministry said that the predictions about the third wave of Covid should be taken very seriously; Sources in the Serum Institute of India said that the production of Covishield has been ramped up to around 110 million doses this month; Today, the Finance Ministry said that keeping in mind the growing demand for holding clerical cadre examinations in public sector banks in local or regional languages, a committee has been formed to look into the matter; Today, Congress slammed the Centre over the surge of prices of petrol and diesel in the country. #CovidThirdWave #Predictions #CovidNorms

Credit: Oneindia    Duration: 02:37Published
India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia [Video]

India's Covidshield wins: 7 European Nations and Switzerland give a green signal| Covid19 | Oneindia

Serum Institute of India's Covishield vaccine has been approved in seven European Union nations and Switzerland amid a row over travel pass. Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain are confirmed as including Covishield. #EU #Covidshield #Covid19

Credit: Oneindia    Duration: 02:02Published

Adar Poonawalla Adar Poonawalla Indian businessman

Adar Poonawalla assures Covidshield-vaccinated Indians facing issues with EU travel| Oneindia News [Video]

Adar Poonawalla assures Covidshield-vaccinated Indians facing issues with EU travel| Oneindia News

Serum Institute CEO Adar Poonawalla tweeted Monday to reassure Covishield-vaccinated Indians facing issues with travel to the European Union - in light of the EU's new 'vaccine passport' scheme not recognising the drug. Poonawalla said he had taken this up at the highest levels" and that he hoped the matter would be resolved soon. #AdarPoonawalla #Covidshield #EUTravel

Credit: Oneindia    Duration: 02:01Published
Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News [Video]

Lucknow man files complaint against Adar Poonawalla for 'no antibodies' despite jab | Oneindia News

A man in Lucknow has filed a complaint against Serum Institute of India CEO Adar Poonawalla and others, alleging that he did not develop antibodies despite taking a Covishield dose. The complaint has been filed at Aashiana police station in Lucknow. Meanwhile, the complainant has threatened to move court if an FIR is not registered against the people mentioned in his complaint. #AdarPoonawalla #Covidshield #SerumInstitute

Credit: Oneindia    Duration: 01:48Published

You Might Like


Related videos from verified sources

Covid-19: PM Modi interacts with 3 teams working on vaccine development [Video]

Covid-19: PM Modi interacts with 3 teams working on vaccine development

Prime Minister Narendra Modi interacted with three teams working on developing and manufacturing of vaccines against Covid-19. The teams were from Gennova Biopharmaceuticals Ltd, Biological E Ltd, and..

Credit: HT Digital Content     Duration: 01:15Published
Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News [Video]

Serum Institute of India faces legal notice, to file Rs.100 Cr case against volunteer|Oneindia News

After a Covidshield Coronavirus vaccine trial participant claimed that he suffered from a virtual neurological breakdown after being administered a dose, The Serum Institute of India has reacted..

Credit: Oneindia     Duration: 01:16Published
Covid-19 vaccine to be distributed initially in India says Serum Institute CEO [Video]

Covid-19 vaccine to be distributed initially in India says Serum Institute CEO

The CEO of India's Serum Institute says India will get supplies of the Oxford-AstraZeneca vaccine that his organisation produces, first.

Credit: Newsflare STUDIO     Duration: 01:28Published

Related news from verified sources

Adar Poonawalla's SII aims to have 100m doses of AstraZeneca vaccine ready by December

Serum Institute of India (SII) is ramping up production of AstraZeneca's Covid-19 vaccine, aiming to have 100 million doses ready by December for a vaccination...
Mid-Day

India could get Oxford COVID-19 vaccine by April 2021: Serum Institute chief

Vaccine maker Serum Institute of India's CEO Adar Poonawalla on Thursday said the Oxford COVID-19 vaccine should be available for healthcare workers and elderly...
Mid-Day Also reported by •DNAHinduZee NewsIndian Express

COVID-19 vaccine: SII CEO Poonawalla makes big announcement after PM Modi visit

SII CEO Adar Poonawalla said that his company will seek permission for emergency use authorization of 'Covishield' in the next two weeks. 
Zee News Also reported by •DNAMid-Day